03
JUL
2024
Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth Opportunities
Comments : Off
Over 77% Of All Shares Voted; Proposals Received Overwhelming Positive Votes BETHESDA, MD, July 3, 2024 – Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, reported positive results of voting at the Annual Shareholders Meeting on June 29, 2024. Annual Meeting Results There was an exceptionally strong vote turnout at the 2023 Annual Meeting,... Read More